Transferring semisolid drug product manufacturing to a European Contract Development and Manufacturing Organisation requires structured planning across six distinct workstreams: scope definition, contract development and manufacturing organisation selection, Chemistry, Manufacturing and Controls package assembly, analytical method transfer, process characterisation and […]
A contract development and manufacturing organisation’s (CDMO’s) stated capacity for pre-filled syringe production is not the same as its verified, available and scalable capacity. For development and operations leaders making long-term sourcing decisions, understanding this distinction is essential. The metrics […]
From Clinic to Commercial Fill-Finish: A Guide for Biologic Manufacturing As biologic programmes transition from development to commercial fill-finish operations, the focus shifts from flexibility and speed to demonstrable understanding, validation, and lifecycle readiness. This phase is critical for ensuring […]
When a small molecule development programme involves a high-potency Active Pharmaceutical Ingredient (HPAPI), selecting the right Contract Development and Manufacturing Organisation (CDMO) becomes a decision with direct consequences for operator safety, product quality and regulatory compliance. Containment capability is not […]
Contents Aseptic Fill-Finish for Commercial Pre-Filled Syringe Programmes Supporting Sterile Injectable Formats Manufacturing Site: Maisons-Alfort, France Regulatory Certification and Global Compliance Supply Reliability for Global Programmes Evaluating a European CDMO for Pre-Filled Syringes Discuss Your Programme with Adragos Pharma Pre-Filled […]
Selecting a Contract Development and Manufacturing Organisation for High-Potency Active Pharmaceutical Ingredient small molecule programmes requires a structured, evidence-based evaluation. The critical criteria are: validated Occupational Exposure Band 5 containment, Good Manufacturing Practice certification that explicitly covers the high-potency suite, […]
Get notified on our latest news.
